I. Katayama et K. Nishioka, SUBSTANCE-P AUGMENTS FIBROGENIC CYTOKINE-INDUCED FIBROBLAST PROLIFERATION - POSSIBLE INVOLVEMENT OF NEUROPEPTIDE IN TISSUE FIBROSIS, Journal of dermatological science, 15(3), 1997, pp. 201-206
Sodium-butyrate-pretreated and Con A-stimulated P815 mast cell line ge
nerated 3T3 fibroblast proliferating activity. This fibroblast stimula
tory activity was partially abrogated by three different substance P a
ntagonists such as spantide (NK1 antagonist), FK224 (NK1 and NK2 antag
onist) or FK888 (NK1 antagonist) or anti-substance P antibody. In addi
tion to P815 mastocytoma cell, IL3-dependent, bone marrow-derived mast
cells also generated fibroblast proliferating activity which was also
partially abrogated by substance P antagonists. Anti-fibrogenic cytok
ine antibodies also inhibited mast cell-derived fibroblast proliferati
ng activity. Substance P or histamine augmented fibrogenic cytokine-in
duced fibroblast proliferation which indicates that mast cell-derived
histamine or substance P play an important role in induction of tissue
fibrosis in fibrosing diseases. (C) 1997 Elsevier Science Ireland Ltd
.